Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    MagForce

    MCap

    —

    Last close

    -0.02

    ▲ 0.01 (100.00%)

    DFR Gold

    MCap

    CAD16m

    Last close

    CAD0.10

    ▲ 0.03 (42.86%)

    Context Therapeutics

    MCap

    USD17m

    Last close

    USD1.06

    ▲ 0.19 (21.84%)

  • Sectors

    Sectors

  • Investment Strategy

    Investment Strategy

    View All

    Latest

  • Thematics

    Thematics

    View All Thematics

    Latest

Ergomed – Edison Open House interview

Ergomed – Edison Open House interview

Associated equity: Ergomed

Ergomed is a global full-service contract research outsourcing (CRO) business focused on the United States and EU. It provides Phase I–III clinical services in addition to post-marketing pharmacovigilance (PV) services and is predominantly focused on oncology, orphan drugs, rare diseases and PV.

View this company

Ergomed — 2 videos in collection

< Previous
Next >

You may also be interested in these:

Healthcare

Ergomed - executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free